FWIW findings about adverse events vary considerably:
> The proportion of patients reporting adverse events ranged from 16% to 98% (median 80%) under SSRI treatment and from 17% to 94% (median 70%) under placebo [1]
So the answer IMO depends on whether we can attribute adverse effects to treatment, which is difficult to disentangle from adverse effects of disease
I’m open to being shown more certainty if available from the literature but meta-analyses are high-strength evidence
> The document is literally made for you to read...
It’s disingenuous to assume every PDF is actually crafted to communicate to its recipients, even more so to pretend LLM users are in a position to understand all the PDFs they receive
There’s a lot of gray area where help understanding a document is fully reasonable
Can’t claim to know for sure, but I’d assume some kind of measurement limitations: the resolution and upper/lower limits of pulse ox are probably calibrated to some medical need, not to detect changes beyond what’s medically necessary
This was using equipment in the emergency department of our state's only L1 trauma center and comprehensive stroke center; I presume it was decent as far as medical monitoring equipment goes.
Nice article!
I wrote something similar this year too after seeing the 5-bullet-points of information stretched out with AI homologous slop too many times.
That didn't happen.
And if it did, it wasn't that bad.
And if it was, that's not a big deal.
And if it is, that's not the IDF's fault.
And if it was, they didn't mean it.
And if they did, Gaza deserved it.
Seems like a good question to ask imo. The lack of accountability of crimes against humanity and children and the general apathy and shrug worthy reaction to most people to these issues especially on this site seems relevant commentary.
Their job, in this case, is probably more of a signal than a clear indicator
Plenty of front-running companies have hired plenty of…not-solid or excessively imaginative data scientists
From what the other comments say, this one seems to lack a grounding in science itself, which frankly is par for the course depending on their background
> The proportion of patients reporting adverse events ranged from 16% to 98% (median 80%) under SSRI treatment and from 17% to 94% (median 70%) under placebo [1]
So the answer IMO depends on whether we can attribute adverse effects to treatment, which is difficult to disentangle from adverse effects of disease
I’m open to being shown more certainty if available from the literature but meta-analyses are high-strength evidence
[1] https://www.cambridge.org/core/journals/the-british-journal-...